380 related articles for article (PubMed ID: 15820679)
1. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.
Jones EM; Surewicz WK
Cell; 2005 Apr; 121(1):63-72. PubMed ID: 15820679
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of barriers for interspecies transmissibility of mammalian prions.
Vanik DL; Surewicz KA; Surewicz WK
Mol Cell; 2004 Apr; 14(1):139-45. PubMed ID: 15068810
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.
Apetri AC; Vanik DL; Surewicz WK
Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190
[TBL] [Abstract][Full Text] [Related]
4. Role of N-terminal familial mutations in prion protein fibrillization and prion amyloid propagation in vitro.
Jones EM; Surewicz K; Surewicz WK
J Biol Chem; 2006 Mar; 281(12):8190-6. PubMed ID: 16443601
[TBL] [Abstract][Full Text] [Related]
5. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
6. Conformational diversity in a yeast prion dictates its seeding specificity.
Chien P; Weissman JS
Nature; 2001 Mar; 410(6825):223-7. PubMed ID: 11242084
[TBL] [Abstract][Full Text] [Related]
7. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.
Kundu B; Maiti NR; Jones EM; Surewicz KA; Vanik DL; Surewicz WK
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12069-74. PubMed ID: 14519851
[TBL] [Abstract][Full Text] [Related]
8. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
Baskakov IV; Bocharova OV
Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
[TBL] [Abstract][Full Text] [Related]
9. Structural polymorphism in amyloids: new insights from studies with Y145Stop prion protein fibrils.
Jones EM; Wu B; Surewicz K; Nadaud PS; Helmus JJ; Chen S; Jaroniec CP; Surewicz WK
J Biol Chem; 2011 Dec; 286(49):42777-42784. PubMed ID: 22002245
[TBL] [Abstract][Full Text] [Related]
10. Seeding-dependent propagation and maturation of amyloid fibril conformation.
Yamaguchi K; Takahashi S; Kawai T; Naiki H; Goto Y
J Mol Biol; 2005 Sep; 352(4):952-60. PubMed ID: 16126222
[TBL] [Abstract][Full Text] [Related]
11. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into alternate aggregated prion protein forms.
Polano M; Bek A; Benetti F; Lazzarino M; Legname G
J Mol Biol; 2009 Nov; 393(5):1033-42. PubMed ID: 19720066
[TBL] [Abstract][Full Text] [Related]
13. Steric zipper of the amyloid fibrils formed by residues 109-122 of the Syrian hamster prion protein.
Lee SW; Mou Y; Lin SY; Chou FC; Tseng WH; Chen CH; Lu CY; Yu SS; Chan JC
J Mol Biol; 2008 May; 378(5):1142-54. PubMed ID: 18423487
[TBL] [Abstract][Full Text] [Related]
14. Conformational variations in an infectious protein determine prion strain differences.
Tanaka M; Chien P; Naber N; Cooke R; Weissman JS
Nature; 2004 Mar; 428(6980):323-8. PubMed ID: 15029196
[TBL] [Abstract][Full Text] [Related]
15. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
16. Generation of prion transmission barriers by mutational control of amyloid conformations.
Chien P; DePace AH; Collins SR; Weissman JS
Nature; 2003 Aug; 424(6951):948-51. PubMed ID: 12931190
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins.
Tanaka M; Chien P; Yonekura K; Weissman JS
Cell; 2005 Apr; 121(1):49-62. PubMed ID: 15820678
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
Nazabal A; Hornemann S; Aguzzi A; Zenobi R
J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
[TBL] [Abstract][Full Text] [Related]
19. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M
Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
